VCRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Vicore Pharma Holding AB
$8.85−0.13 (-1.45%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
4 of Vicore Pharma Holding AB's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Oct 31, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 30, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 6-K | Aug 21, 2026 | Aug 21, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 6, 2026 | Jul 6, 2026 | SEC EDGAR |